PaxMedica, Inc. Common Stock
OTC: PXMD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Howard J. Weisman
- Employees
- 6
- Headquarters
- Tarrytown, United States
- IPO year
- 2022
- Market cap
- $63.1K
- Website
- https://www.paxmedica.com
Loading PXMD…
Loading profile data…Frequently asked questions about PXMD
What does PaxMedica, Inc. Common Stock (PXMD) do?
PaxMedica, Inc. is a biopharmaceutical company currently in the clinical development phase, dedicated to advancing anti-purinergic drug therapies (APTs). These innovative treatments are specifically designed to address complex neurological disorders presenting with stubborn and persistent symptoms. The company's primary investigative drug is PAX...
Where does PXMD trade?
PaxMedica, Inc. Common Stock (PXMD) trades on the Other OTC.
What sector is PXMD in?
PaxMedica, Inc. Common Stock (PXMD) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of PaxMedica, Inc. Common Stock?
Howard J. Weisman is the chief executive officer of PaxMedica, Inc. Common Stock (PXMD).
Where is PaxMedica, Inc. Common Stock headquartered?
PaxMedica, Inc. Common Stock is headquartered in United States.
Does PXMD pay a dividend?
PaxMedica, Inc. Common Stock (PXMD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PXMD go public?
PaxMedica, Inc. Common Stock (PXMD) completed its initial public offering in 2022.